RecruitingNCT05750849

Impact of Serum Progesterone Levels on the Day of β-hCG Test in Artificial Cycles on the Ongoing Pregnancy Rate.


Sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA

Enrollment

900 participants

Start Date

Jan 25, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective cohort multicentric study including infertile patients undergoing a pregnancy test on βhCG day (around ET +11), after an ET in the context of an artificial cycle and receiving LPS with vaginal natural progesterone following the clinical practice in IVI RMA (Spain).


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Inclusion Criteria4

  • The subject must provide written informed consent prior to any study related procedures
  • Women ≤50 years old
  • BMI ≤ 35 kg/m2
  • Adequate endometrial thickness (>6.5mm) and pattern (Triple A structure) in the proliferative phase

Exclusion Criteria2

  • Uterine Pathology, adnexal pathology
  • Systemic diseases

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBLOOD COLLECTION FOR P4 DETERMINATION

Serum progesterone levels on the pregnancy test day


Locations(1)

IVI RMA Valencia

Valencia, Valencia, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05750849


Related Trials